ArticleCell discovery2015

EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway.

Fumihiko Murai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.